儿科神经炎光学谱障碍 儿科神经炎光学谱障碍
Kelsey Poisson1, Karen Moeller2, Kristen S Fisher3
1Department of Neurology, University of Alabama at Birmingham, Birmingham, AL; Department of Pediatrics, Division of Pediatric Neurology, Children's of Alabama, Birmingham, AL.
Seminars in pediatric neurology
|July 14, 2023
概括
神经脊髓炎光学谱系障碍 (NMOSD) 是一种罕见的儿科脱髓化疾病. 早期诊断和治疗至关重要,因为超过一半的AQP4-IgG血清阳性NMOSD儿童面临永久残疾.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 神经脊髓炎光学谱系障碍 (NMOSD) 是一种严重的脱髓化自身免疫性疾病.
- 它的特征是星细胞病变,通常涉及对水-4 (AQP4) 水道的抗体.
- 儿科NMOSD很少见,占病例的3-5%,在黑人或东亚血统的人群中更为常见.
研究的目的:
- 总结儿科神经炎光学谱障碍的关键方面.
- 突出儿童NMOSD的临床表现,诊断标志物和治疗选择.
- 要强调与儿科NMOSD相关的长期残疾风险.
主要方法:
- 对儿科NMOSD现有文献的综述.
- 核心临床综合征和诊断标准的分析.
- 评估当前和新兴的治疗策略.
主要成果:
- 儿科NMOSD表现为综合征,包括视神经炎,骨髓炎和脑干/脑膜干涉.
- 水素-4IgG (AQP4-IgG) 血清阳性是一种关键的诊断标记.
- 第一线治疗包括利图西马布,阿扎西奥普林和mycophenolate mofetil.
结论:
- 儿科NMOSD带有永久视力和运动残疾的高风险,影响超过50%的AQP4-IgG阳性儿童.
- 虽然新型成人疗法正在出现,但儿科治疗侧重于已建立的免疫抑制剂.
- 对儿科特异性NMOSD治疗的进一步研究是有必要的.
相关概念视频
Photoreceptors and Visual Pathways
6.1K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.1K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K


